Core A: Administrative Core
Core A: Administrative Core
批准号:
10363642
负责人:
Steven P. Balk
金额:
$8.66万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-05-24 至 2024-01-31
关键词:
AddressAdministratorAndrogen ReceptorBiologicalBiometryCancer CenterCell LineClinicClinicalClinical DistributionClinical InvestigatorClinical TrialsClinical Trials DesignCodeCollaborationsCommunicationComputational BiologyConsultationsDana-Farber Cancer InstituteDataDiseaseEnsureExperimental DesignsFoundationsGene ExpressionGoalsGrantGroup MeetingsImageInstitutionIntervention TrialIsraelLaboratory FindingLaboratory StudyMedical centerPathologicPatientsPhase I Clinical TrialsPhase I/II Clinical TrialPhase II Clinical TrialsPhysiologicalProteinsRelapseReproducibilityResourcesSample SizeSamplingStatistical Data InterpretationTissuesTranslatingUniversitiesWashingtonXenograft Modelbasecastration resistant prostate cancerclinically relevantclinically significantdesigninsightpre-clinicalpreclinical developmentpreclinical studypreclinical trialresponse
中文摘要
行政核心(核心A)在目前的赠款期间履行了三大职能,
并将继续这样做,在这一更新。一个功能是P01的整体管理,
这是PI Steven Balk与管理员的责任,并与
其他的私家侦探这包括解决所有行政问题,组织小组会议,
组织内部和外部审查,并在一般情况下促进沟通,
合作。核心小组的第二项职能是协助项目努力,
确保他们的实验室研究和发现具有生理学意义,并最终
将他们的发现应用到病人身上与我们的密切互动促进了这一点。
临床医生,由我们的内部顾问委员会代表。通过既往/正在进行的临床试验
和组织库的工作,这些临床研究者
收集(并继续收集)有价值的样本,从病人在不同阶段的,
疾病和不同的治疗后。在与项目负责人的讨论中,他们提供了
相关临床样本进行分析,并提供了进一步了解潜在的生物学
实验室检查结果的重要性。第三个核心职能是为以下方面提供统计支持:
每个项目负责人在他们的实验设计。具体目标是:(1)提供
行政支持,以确保项目目标的实现,2)协助
将每个项目的结果转化为临床,3)为每个项目提供生物统计支持
项目
英文摘要
The Administrative Core (Core A) has fulfilled three major functions during the current grant,
and will continue to do so in this renewal. One function is the overall management of the P01,
which is the responsibility of the PI, Steven Balk, with an administrator and in consultation with
the other PIs. This includes addressing all administrative issues, organizing group meetings,
organizing internal and external reviews, and in general facilitating communications and
collaborations. The second function of the Core has been to assist the Projects in efforts to
ensure that their laboratory studies and findings are physiologically significant, and ultimately to
translate their findings into patients. This has been facilitated by close interactions with our
clinicians, represented by our internal advisory board. Through previous/ongoing clinical trials
and tissue banking efforts at their respective institutions, these clinical investigators have
collected (and continue to collect) valuable samples from patients at varying stages of their
disease and after varying therapies. In discussions with the Project Leaders, they have provided
relevant clinical samples for analysis and have provided further insight into potential biological
significance of laboratory findings. The third Core function is to provide statistical support for
each of the Project Leaders in their experimental designs. The Specific Aims are 1) Provide
administrative support to insure that the goals of the project are achieved, 2) Assist in
translating the results from each Project into the clinic, 3) Provide biostatistical support for each
Project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DF/HCC Prostate SPORE
-
批准号:10628270
-
项目类别:
-
资助金额:$258.56万
-
财政年份:2023
-
负责人:Steven P. Balk
-
依托单位:
WNT5a/ROR2-Mediated Hippo Pathway Activation in Prostate Cancer
-
批准号:10734173
-
项目类别:
-
资助金额:$39.55万
-
财政年份:2023
-
负责人:Steven P. Balk
-
依托单位:
Enhancing the Efficacy of Docetaxel in Prostate Cancer
-
批准号:10665071
-
项目类别:
-
资助金额:$64.14万
-
财政年份:2022
-
负责人:Steven P. Balk
-
依托单位:
Prostate Cancer Vulnerabilities to BH3 Mimetic Drugs
-
批准号:10407648
-
项目类别:
-
资助金额:$39.23万
-
财政年份:2021
-
负责人:Steven P. Balk
-
依托单位:
Prostate Cancer Vulnerabilities to BH3 Mimetic Drugs
-
批准号:10279279
-
项目类别:
-
资助金额:$40.03万
-
财政年份:2021
-
负责人:Steven P. Balk
-
依托单位:
SOX9 Mediation of AR and ERG Driven Prostate Cancer
-
批准号:9477598
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2014
-
负责人:Steven P. Balk
-
依托单位:
SOX9 Mediation of AR and ERG Driven Prostate Cancer
-
批准号:8653225
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2014
-
负责人:Steven P. Balk
-
依托单位:
SOX9 Mediation of AR and ERG Driven Prostate Cancer
-
批准号:9269164
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2014
-
负责人:Steven P. Balk
-
依托单位:
Androgen Receptor Action in Castration Resistant Prostate Cancer
-
批准号:8475909
-
项目类别:
-
资助金额:$218.35万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Project 2: Mechanisms Driving AR Full Length and Splice Variant Activities and Antagonist Resistance
-
批准号:10363640
-
项目类别:
-
资助金额:$23.74万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Androgen Receptor Action in Castration Resistant Prostate Cancer
-
批准号:10363638
-
项目类别:
-
资助金额:$142.94万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Androgen Receptor Action in Castration Resistant Prostate Cancer
-
批准号:10576935
-
项目类别:
-
资助金额:$143.19万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Project 2: Mechanisms Driving AR Full Length and Splice Variant Activities and Antagonist Resistance
-
批准号:10576938
-
项目类别:
-
资助金额:$23.75万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Basis for Androgen Receptor Antagonist Resistance in CRPC
-
批准号:8475911
-
项目类别:
-
资助金额:$29.28万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Androgen Receptor Action in Castration Resistant Prostate Cancer
-
批准号:8665884
-
项目类别:
-
资助金额:$201.08万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Androgen Receptor Action in Castration Resistant Prostate Cancer
-
批准号:9099781
-
项目类别:
-
资助金额:$204.51万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Administrative/Clinical/Biostatistics Core
-
批准号:8475914
-
项目类别:
-
资助金额:$14.15万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Core A: Administrative Core
-
批准号:10576941
-
项目类别:
-
资助金额:$8.82万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Targeting androgen receptor signaling in prostate cancer in men with African ancestry
-
批准号:10490377
-
项目类别:
-
资助金额:$9.63万
-
财政年份:2010
-
负责人:Steven P. Balk
-
依托单位:
Targeting androgen receptor signaling in prostate cancer in men with African ancestry
-
批准号:10693241
-
项目类别:
-
资助金额:$17.15万
-
财政年份:2010
-
负责人:Steven P. Balk
-
依托单位:
海外基金